- Home
- CBUS vs CVM Comparison
CBUS vs CVM Comparison
Compare CBUS & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- CVM
- Stock Information
- Founded
- CBUS 2010
- CVM 1983
- Country
- CBUS United States
- CVM United States
- Employees
- CBUS N/A
- CVM N/A
- Industry
- CBUS Agricultural Chemicals
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CBUS Industrials
- CVM Health Care
- Exchange
- CBUS Nasdaq
- CVM Nasdaq
- Market Cap
- CBUS 72.0M
- CVM 71.2M
- IPO Year
- CBUS 2017
- CVM 1987
- Fundamental
- Price
- CBUS $1.38
- CVM $9.05
- Analyst Decision
- CBUS Strong Buy
- CVM
- Analyst Count
- CBUS 3
- CVM 0
- Target Price
- CBUS $22.00
- CVM N/A
- AVG Volume (30 Days)
- CBUS 197.4K
- CVM 297.1K
- Earning Date
- CBUS 11-06-2025
- CVM 08-14-2025
- Dividend Yield
- CBUS N/A
- CVM N/A
- EPS Growth
- CBUS N/A
- CVM N/A
- EPS
- CBUS N/A
- CVM N/A
- Revenue
- CBUS $4,846,000.00
- CVM N/A
- Revenue This Year
- CBUS $17.67
- CVM N/A
- Revenue Next Year
- CBUS $63.43
- CVM N/A
- P/E Ratio
- CBUS N/A
- CVM N/A
- Revenue Growth
- CBUS 63.66
- CVM N/A
- 52 Week Low
- CBUS $1.20
- CVM $1.98
- 52 Week High
- CBUS $6.10
- CVM $38.70
- Technical
- Relative Strength Index (RSI)
- CBUS 48.79
- CVM 47.29
- Support Level
- CBUS $1.32
- CVM $9.58
- Resistance Level
- CBUS $1.41
- CVM $12.68
- Average True Range (ATR)
- CBUS 0.08
- CVM 1.09
- MACD
- CBUS 0.01
- CVM -0.37
- Stochastic Oscillator
- CBUS 52.31
- CVM 7.75
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.